Table 4.
Genetic Model | First Author, Publication Year | NSCL/P | Control | Weight | Odds Ratio | ||
---|---|---|---|---|---|---|---|
Events | Total | Events | Total | M-H, Fixed, 95%CI | |||
A vs. C | Fontoura, 2012 | 243 | 766 | 306 | 806 | 26.6% | 0.76 [0.62, 0.94] |
Mostowska, 2012 | 183 | 412 | 422 | 892 | 19.4% | 0.89 [0.70, 1.13] | |
Mi, 2015 | 179 | 444 | 265 | 648 | 16.8% | 0.98 [0.76, 1.25] | |
Babu Gurramkonda, 2015 | 138 | 288 | 151 | 352 | 9.2% | 1.22 [0.90, 1.67] | |
Velázquez-Aragón, 2016 | 125 | 260 | 237 | 510 | 10.9% | 1.07 [0.79, 1.44] | |
Wu, 2018 | 186 | 496 | 224 | 560 | 17.2% | 0.90 [0.70, 1.15] | |
Subtotal (95%CI) | 2666 | 3768 | 100.0% | 0.92 [0.83, 1.02] | |||
Total Events | 1054 | 1605 | |||||
Heterogeneity: Chi2 = 7.74, df = 5 (p = 0.17); I2 = 35%; Test for overall effect: Z = 1.57 (p = 0.12) | |||||||
AA vs. CC | Fontoura, 2012 | 44 | 228 | 57 | 211 | 26.6% | 0.65 [0.41, 1.01] |
Mostowska, 2012 | 29 | 108 | 94 | 250 | 23.1% | 0.61 [0.37, 1.00] | |
Babu Gurramkonda, 2015 | 35 | 76 | 32 | 89 | 8.8% | 1.52 [0.81, 2.84] | |
Mi, 2015 | 36 | 115 | 54 | 167 | 16.8% | 0.95 [0.57, 1.59] | |
Velázquez-Aragón, 2016 | 27 | 59 | 53 | 124 | 10.3% | 1.13 [0.61, 2.11] | |
Wu, 2018 | 30 | 122 | 35 | 126 | 14.4% | 0.85 [0.48, 1.50] | |
Subtotal (95%CI) | 708 | 967 | 100.0% | 0.85 [0.68, 1.05] | |||
Total Events | 201 | 325 | |||||
Heterogeneity: Chi2 = 7.49, df = 5 (p = 0.19); I2 = 33%; Test for overall effect: Z = 1.52 (p = 0.13) | |||||||
CA vs. CC | Fontoura, 2012 | 155 | 339 | 192 | 346 | 31.0% | 0.68 [0.50, 0.91] |
Mostowska, 2012 | 98 | 177 | 196 | 352 | 17.6% | 0.99 [0.69, 1.42] | |
Mi, 2015 | 107 | 186 | 157 | 270 | 16.3% | 0.97 [0.67, 1.42] | |
Babu Gurramkonda, 2015 | 68 | 109 | 87 | 144 | 8.5% | 1.09 [0.65, 1.81] | |
Velázquez-Aragón, 2016 | 71 | 103 | 131 | 202 | 8.3% | 1.20 [0.72, 2.00] | |
Wu, 2018 | 126 | 218 | 154 | 245 | 18.4% | 0.81 [0.56, 1.18] | |
Subtotal (95% CI) | 1132 | 1559 | 100.0% | 0.88 [0.75, 1.03] | |||
Total Events | 625 | 917 | |||||
Heterogeneity: Chi2 = 5.93, df = 5 (p = 0.31); I2 = 16%; Test for overall effect: Z = 1.57 (p = 0.12) | |||||||
CA + AA vs. CC | Fontoura, 2012 | 199 | 383 | 249 | 403 | 31.1% | 0.67 [0.50, 0.89] |
Mostowska, 2012 | 127 | 206 | 290 | 446 | 18.7% | 0.86 [0.61, 1.22] | |
Babu Gurramkonda, 2015 | 103 | 144 | 119 | 176 | 8.1% | 1.20 [0.74, 1.95] | |
Mi, 2015 | 143 | 222 | 211 | 324 | 16.3% | 0.97 [0.68, 1.39] | |
Velázquez-Aragón, 2016 | 98 | 130 | 184 | 255 | 8.2% | 1.18 [0.73, 1.92] | |
Wu, 2018 | 156 | 248 | 189 | 280 | 17.6% | 0.82 [0.57, 1.17] | |
Subtotal (95%CI) | 1333 | 1884 | 100.0% | 0.87 [0.75, 1.00] | |||
Total Events | 826 | 1242 | |||||
Heterogeneity: Chi2 = 7.05, df = 5 (p = 0.22); I2 = 29%; Test for overall effect: Z = 1.91 (p = 0.06) | |||||||
AA vs. CC + CA | Mostowska, 2012 | 29 | 206 | 94 | 446 | 23.6% | 0.61 [0.39, 0.97] |
Fontoura, 2012 | 44 | 383 | 57 | 403 | 22.8% | 0.79 [0.52, 1.20] | |
Babu Gurramkonda, 2015 | 35 | 144 | 32 | 176 | 10.1% | 1.44 [0.84, 2.48] | |
Mi, 2015 | 36 | 222 | 54 | 324 | 17.0% | 0.97 [0.61, 1.53] | |
Velázquez-Aragón, 2016 | 27 | 130 | 53 | 255 | 13.1% | 1.00 [0.59, 1.68] | |
Wu, 2018 | 30 | 248 | 35 | 280 | 13.4% | 0.96 [0.57, 1.62] | |
Subtotal (95%CI) | 1333 | 1884 | 100.0% | 0.89 [0.74, 1.09] | |||
Total Events | 201 | 325 | |||||
Heterogeneity: Chi2 = 6.39, df = 5 (p = 0.27); I2 = 22%; Test for overall effect: Z = 1.12 (p = 0.26) |
Abbreviations: NSCL/P, non-syndromic cleft lip with or without a cleft palate; CI, confidence interval.